Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2019

Oct 10, 2019

31565_dirs_2019-10-10_82dc1650-99e9-49bb-923b-e63c03c218b3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-10-08

Reporting Person: Basil Michelle L (EVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-08 Common Stock S 8883 $122.34 Disposed 23771 Direct
2019-10-09 Common Stock S 1100 $122.50 Disposed 22671 Direct
2019-10-09 Common Stock S 3724 $123.50 Disposed 18947 Direct
2019-10-09 Common Stock S 5809 $124.54 Disposed 13138 Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain performance share units previously reported in Table I on October 8, 2019. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: This number includes unvested restricted stock units previously reported.

F3: Transaction pursuant to an existing 10b5-1 trading plan.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.02 to $123.00, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.09 to $124.02, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.09 to $124.96, inclusive.